Revenue | ₹58.60Cr |
Net Profits | ₹-9.84Cr |
Net Profit Margins | -16.79% |
Mangalam Drugs and Organics Ltd’s revenue fell -34.05% since last year same period to ₹58.60Cr in the Q3 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated 18.22% jump in its revenue since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit fell -862.79% since last year same period to ₹-9.84Cr in the Q3 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -33.88% fall in its net profits since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit margin fell -1256.55% since last year same period to -16.79% in the Q3 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -13.25% fall in its net profit margins since last 3-months.
The revenue for Mangalam Drugs and Organics Ltd in the Q3 results 2025 was ₹58.60Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q3 results 2025 was ₹-9.84Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q3 results 2025 was -16.79%.
The revenue for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was ₹88.85Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was ₹1.29Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was 1.45%.